Severe insulin resistance secondary to insulin antibodies: Successful treatment with the immunosuppressant MMF

Pediatric Diabetes

Volumn 9, Issue 3 PART 1, 2008, Pages 250-254

  Segal, T ^a   Webb, E A ^a   Viner, R ^a   Pusey, C ^b   Wild, G ^c   Allgrove, Jeremy ^d  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Protein Reference Unit   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Immunoabsorption; Immunosuppressants; Insulin analogues; Insulin antibodies; Mofetil; Mycophenolate; Steroids

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; DOMPERIDONE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; INSULIN; INSULIN ANTIBODY; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ONDANSETRON; PREDNISOLONE;

ANOREXIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; CUSHINGOID SYNDROME; DIABETIC KETOACIDOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IMMUNOADSORPTION; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD;

BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN ANTIBODIES; INSULIN RESISTANCE; MALE; MYCOPHENOLIC ACID; PREDNISOLONE;

EID: 44649202867     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00408.x     Document Type: Article

References (12)

1. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993: 16 (Suppl. 3): 155-165.
2. Van Haeften TW. Clinical significance of insulin antibodies in insulin-treated diabetic patients. Diabetes Care 1989: 12: 641-648.
3. Lahtela JT, Knip M, Paul R, Antonen J, Salmi J. Severe antibody mediated human insulin resistance: Successful treatment with the insulin analog lispro. A case report. Diabetes Care 1997: 20: 71-73.
4. Matsuyoshi A, Shimoda S, Tsuruzoe K et al. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy. Diabetes Res Clin Pract 2006: 72: 238-243.
5. Ganz MA, Unterman T, Roberts M et al. Resistance and allergy to recombinant human insulin. J Allergy Clin Immunol 1990: 86: 45-51.
6. Koyama R, Nakanishi K, Kato M, Yamashita S, Kuwahara H, Katori H. Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: Treatment with double filtration plasmapheresis and prednisolone. Am J Med Sci 2005: 329: 259-264.
7. Maneschi F, Fineberg SE, Kohner EM. Successful treatment of immune mediated insulin resistance by human insulin (recombinant DNA). Diabetes Care 1982: 5 (Suppl. 2): 175-179.
8. Griffin SV, Lockwood CM, Pusey CD. Plasmapheresis and immunoadsorption. In: Austen KF, Burakoff SJ, Rosen FS, Strom TB, eds. Therapeutic Immunology, 2nd edn. Cambridge: Blackwell Science, 2001: 597-611.
9. Shipp JC, Cunningham RW, Russell RO, Marble A. Insulin resistance: clinical features, natural course and effects of steroid treatment. Medicine (Baltimore) 1965: 44: 165-186.
10. Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005: 80: S181-S190.
11. Kuerzel GU, Shukla U, Scholtz HE et al. Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin 2003: 19: 34-40.
12. Owens D, Vora J. Insulin aspart: A review. Expert Opin Drug Metab Toxicol 2006: 2: 793-804.